<DOC>
	<DOCNO>NCT00701181</DOCNO>
	<brief_summary>To evaluate effectiveness study drug improve visual acuity compare laser treatment patient diabetic macular edema</brief_summary>
	<brief_title>Study Evaluating Efficacy Safety PF-04523655 Versus Laser Subjects With Diabetic Macular Edema</brief_title>
	<detailed_description>DEGAS termination decision date December 17 , 2010 . Rationale : objective study could longer achieve . The study terminate safety .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<criteria>Patients Diabetes Mellitus ( Type 1 Type 2 ) Showing Diabetic Macular Edema Eye . Proliferative Diabetic Retinopathy Study Eye . Subjects Receiving Concomitant Intravitreal AntiVEGF Therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Phase II</keyword>
	<keyword>Prospective</keyword>
	<keyword>Randomized</keyword>
	<keyword>Diabetic Macular Edema</keyword>
	<keyword>PF-04523655</keyword>
	<keyword>Laser</keyword>
</DOC>